Sylebra Capital (HK)’s CNOVA N.V. CNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-784,947
Closed -$4.3M 22
2016
Q4
$4.3M Sell
784,947
-36,939
-4% -$201K 0.43% 17
2016
Q3
$4.41M Hold
821,886
0.39% 18
2016
Q2
$4.07M Sell
821,886
-331,215
-29% -$1.4M 0.38% 16
2016
Q1
$3.46M Sell
1,153,101
-17,698
-2% -$42.4K 0.33% 17
2015
Q4
$2.82M Hold
1,170,799
0.27% 18
2015
Q3
$3.54M Hold
1,170,799
0.64% 12
2015
Q2
$6.47M Buy
1,170,799
+29,412
+3% +$176K 0.83% 13
2015
Q1
$7.18M Buy
1,141,387
+944,705
+480% +$6.22M 1.56% 11
2014
Q4
$1.56M Buy
+196,682
New +$1.42M 0.55% 9

Other funds holding CNV

Sylebra Capital (HK)'s CNV Position: Q1 2017 in Review

Sylebra Capital (HK) sold out of CNOVA N.V. (CNV) in Q1 2017, closing a stake of 784,947 shares — an estimated $4.3M sold.

Sylebra Capital (HK) first reported a position in CNV in Q4 2014 and held it in 9 quarters. The position peaked at $7.18M in Q1 2015. 2 funds tracked by Wall St. Rank hold CNV as of Q1 2017.

  • Sylebra Capital (HK) reported no remaining CNOVA N.V. position as of Q1 2017 after selling out during the quarter.
  • Sylebra Capital (HK) sold 784,947 CNOVA N.V. shares in Q1 2017, an estimated $4.3M.
  • Sylebra Capital (HK) first reported a position in CNOVA N.V. in Q4 2014 and held it in 9 quarters.
  • Sylebra Capital (HK)'s CNOVA N.V. position peaked at $7.18M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held CNOVA N.V. as of Q1 2017.

Based on Sylebra Capital (HK)'s 13F filing for Q1 2017, filed 15 May 2017.